مواقع التدريسيينجامعة الكوفة
د.حيدر فرحان سلمان الزبيدي
أستاذ مساعد

د.حيدر فرحان سلمان الزبيدي

English Version
0بحث منشور
0محاضرة

الملف الشخصي

حاصل على شهادة بكلوريوس علوم صيدلة /كلية الصيدلة /جامعة الكوفة سنة 2004
حاصل على شهادة الماجستير في الكيمياء الحياتية السريرية كلية الطب /جامعة الكوفة سنة 2010
حاصل على شهادة الدكتوراه في الكيمياء الحياتية السريرية كلية الطب /جامعة الكوفة سنة 2018
معيد في كلية الصيدلة جامعة الكوفة من سنة 2005 الى 2009
محاضر خارجي في المعهد التقني الكوفة /قسم الصيدلة من سنة 2005 الى 2007
عضو هيئة تدريسية كلية الصيدلة /جامعة الكوفة من سنة 2010 ولحد الان
امين مجلس كلية الصيدلة من 2011 الى 2012
مقرر فرع العقاقير من 2012 الى 2014
رئيس فرع العقاقير والنباتات الطبية من 2019 الى 2022
معاون العميد للشؤون العلمية من 2022 ولحد الان

البحوث المنشورة

5
Number 6, 2021,

Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels

الباحثونDuhaidahawi, Dunya Al، Hasan, Samer A.; Al Zubaidy, Haider F.S
المجلةCurrent Diabetes Reviews,
مختصر البحث

Background: For thousands of years, natural food products have been used as a medicine for treating diseases that affect the human body, including diabetes mellitus (DM). Lately, several investigations have been performed on the flavonoid derivatives of plant origin, and their biological activity has been extensively studied. Methods: Given our need to know more mechanisms for treating DM, we performed a thorough research review on treating diabetes mellitus based on flavonoids, their therapeutic potential, and biological action. Results: Flavonoids reduce complications in addition to their vital role as effective supplements for preventing diabetes mellitus by regulating glucose metabolism, lipid profile, liver enzyme activity, a protein kinase inhibitor, PPAR, and AMPK with NF-ΚB. Conclusion: The articles that we reviewed showed the positive role of flavonoids, which in a certain way reduce diabetes, but their side effects still need to be studied further.This review is focused on describing the different types of dietary flavonoids along with their mechanisms of reducing blood glucose and enhancing insulin sensitivity, as well as their side effects.

Nov 2020

PIRA-PCR technique is a resolve for any unavailable restriction enzyme of single nucleotide polymorphism

الباحثونShaden M. H. Mubarak1، Dhafer A. F. Al-Koofee2, Haider F. S. Al-Zubaidy
المجلةAnnals of Tropical Medicine and Public Health
مختصر البحث

Abstract Primer-Introduced Restriction Analysis Polymerase Chain Reaction (PIRA-PCR) is good simple useful technique for detection mutation point via makes or terminates artificial restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) that different restriction position for any identified enzyme in the area of the mutation point in any type of the genomes; human, animal, or plant.The method depending on using this software:http://primer1.soton.ac.uk/primer2.htmlwhich is available freely. The designing primer pairs completed by using it, with sieves for the appropriate mismatches. This way is essential to format a simulated restriction enzyme that recognition locations at great sensitivity and accuracy of assessment reach 0.2 ng/ml and 3% respectively of mutant and wild type alleles. This paper gives a simple clarification to use a web-based computer tool to improve the researchers' skills to get the .best results in the PCR-world techniques

Jul-Sep2021,

Design and Synthesis of Sulindac New Derivitives as Possible Mutual Prodrug with Potential to Maximized Therapeutic Area.

الباحثونHussein Mubarak, Ahmed Kareem;، Radhi Alhasnaway, Ahmed Wheed; Al-zubaidy, Haider F. S.
المجلةIndian Journal of Forensic Medicine & Toxicology
مختصر البحث

Abstract: The urgent necessity today for development of anti cancer agent is crucial so highly dependent for searching for new anti neoplastic action, the drug discovery process is costly and consume long time, in my study focusing my efforts toward drug optimization process using sulindac (NSAID) which has a fantastic attractive area as anti cancer and anticancer in addition to it is anti inflammatory action. The study describes design and synthesis of mutual pro-drug of sulindac in combination with thenatural anti oxidants (menthol, thymol, vanillin, guiacol) as a single integral pharmaceutical unit byan chloro acetyl chlorideas spacer to form an ester mutual prodrug with expected to improve the anti inflammatory, anti cancer, antioxidant action of sulindac by the conjugation with natural anti oxidative integral moiety and minimized the ulcerogenic adverse effect of sulindacit is carboxylic acid functionality. The synthesis is conferred byH1NMR, FT-IR, CHN and physiochemical properties. Copyright of Indian Journal of Forensic Medicine & Toxicology is the property of Institute of Medico-legal publications Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.

5 January 2022

Synthesis, anti-inflammatory effects, molecular docking and molecular dynamics studies of 4-hydroxy coumarin derivatives as inhibitors of COX-II enzyme

الباحثونDunyaAL-Duhaidahawi، Haider F.S. AL-Zubaidy Khattab Al-Khafaji
المجلةJournal of Molecular Structure
مختصر البحث

Abstract The research aimed to investigate the anti-inflammatory effect of 4-hydroxy coumarin derivatives on inflammatory response in rats and to estimate the toxicity of enumerated compounds (3-11) following acute exposure. Toxicity report was collected by oral dosing administered individually to rats on a scale of 10-3000 mg/kg, while an indication of toxicity was observed for ten days following the last given dose. The response to inflammation was estimated using the model of xylene-induced edema and the model of carrageenan-inflammation of the paw. Compounds were administered orally to animals at a once-daily dose for seven sequential days. Molecular docking studies with COX-II enzyme were used to explain deeply the activity of synthesized compounds. Furthermore, the in-silico results were quite consistent with biological activity. Interestingly, compounds 5 and 10 showing the highest binding points (lower values). Therefore, the molecular dynamics simulation study of the most active compounds 5 and 10 was performed.

2022/4/1

Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer

الباحثونHaider Farhan Salman Alzubaidy، SR Majeed, DA Al-Koofee
المجلةRazi Vaccine & Serum Research Institute
مختصر البحث

The present study aimed to examine the polymorphism -938C > A of BCL-2 gene and promoter -248G>A in the Bax gene, as well as their relationship with specific clinical-pathological characteristics, in patients with breast cancer. Blood samples were obtained from 70 patients who had been diagnosed with breast cancer and 34 healthy women as the control group. Polymorphic analysis was performed using the polymerase chain reaction-restriction fragment length polymorphism assay. Anthropometric data were assessed. Estrogen receptor (ER), human epidermal growth factor receptor 2 (Her-2), and progesterone receptor (PR) were measured by immunohistochemistry. The data of age and body mass index (BMI) demonstrated no significant variations between the two groups (P>0.05). The results of HER-2 revealed that 42.86% of breast cancer patients reflected positively for Her-2/neu expression, while 24.29% reflected negative results of Her-2/neu. Moreover, the results of ER revealed that 42.86% and 28.57% of subjects were positive and negative ER, respectively; moreover, the missing data was 28.57%. In addition, the results of PR indicated that 35.71% of patients (25/70) were positive for PR, while 28.57% reflected negative results, and the missing results were 35.71%. The genotype and allele frequencies of BCL-2(-938C>A) were not statistically significant in women with breast cancer and the control group (P=0.574, P=0.533) for heterozygous and recessive models, respectively. The genotype of BCL-2(-938C>A) in control and patients in codominant, dominant, recessive, and additive models demonstrated no significant variations of all genotypes in all groups. Genotypes and allele frequencies for Bax (-248G>A) in patients with breast cancer and control indicated that the frequencies of GG, AG, and AA genotypes in cases were 16.67%, 3.33%, and 80 %, while in controls, these values were 3.23 %, 58.06 %, and 3.23 %, respectively. The heterozygous genotype (AG) in the codominant model was OR=36.00 (95% CI: 4.5608 - 284.1608; P=0.0007). In comparison with the wild type (GG), there was a 36-fold increase in the risk of breast cancer. Furthermore, the findings of this study revealed a significant correlation between Bax (-248G>A) polymorphism and breast cancer risk under the dominant and overdominant (OR=6.33; 95% CI: 2.2604 -17.7452; P=0.0004, and OR=40.154; 95% CI: 5.1365 - 313.8949; P=0.0004, respectively. The recessive model revealed that there was a decreased risk of breast cancer (OR= 0.167; 95% CI: 0.0303 to 0.9168; P=0.039). Based on the results, it can be concluded that there were no significant variations in BCL-2 (-938C>A) polymorphism of all genotypes models when breast cancer women are compared with healthy ones. In a similar vein, there was no significant association between the BCL-2 (-938C>A) polymorphism and breast cancer risk under dominant, codominant, or recessive models.

المحاضرات

6
عرض التفاصيل